Parametric Portfolio Associates’s Adicet Bio ACET Stock Holding History

Parametric Portfolio Associates’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$430K	Sell	1,347 -11	-0.8%	-$2.53K	﹤0.01%	3158
2021 Q4	$380K	Buy	1,358 +278	+26%	+$47.7K	﹤0.01%	3179
2021 Q3	$136K	Buy	+1,080	New	+$134K	﹤0.01%	3495
2020 Q3	–	Sell	-224	Closed	-$54K	–	3922
2020 Q2	$54K	Buy	+224	New	+$44K	﹤0.01%	3855
2019 Q4	–	Sell	-119	Closed	-$118K	–	3956
2019 Q3	$118K	Sell	119 -9	-7%	-$10K	﹤0.01%	3808
2019 Q2	$146K	Buy	+128	New	+$116K	﹤0.01%	3797

Other funds holding ACET

OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return